U.S. stocks advanced Wednesday after the Treasury Department announced it will at least double its planned buybacks of 10- and 30-year Treasurys through Nov. 4, citing a need to "provide greater liquidity support in longer-dated nominal sectors where there is consistent strong sponsorship from market participants."
The immediate impact was measurable: the 10-year Treasury yield fell to 4.64 percent from 4.71 percent, while the 30-year—recently at its highest level since 2007—dropped to 5.18 percent from 5.28 percent. Yet context matters. The 10-year remains 67 basis points above its 3.97 percent level before summer's yield surge, which was driven by persistent inflation concerns and expanding government debt issuance.
BNP Paribas strategists flagged a critical structural problem: the buyback program's scale is insufficient. The Treasury's repurchase commitment represents only a fraction of the total longer-dated bond market, making it a tactical relief measure rather than a durable solution. More damaging to the bulls' case is what strategists called "challenged Fed credibility." Investors remain uncertain whether the Federal Reserve will raise the federal funds rate to align with Fed Chair Kevin Warsh's stated commitment to bringing inflation to the 2 percent target. BNP Paribas concluded that buybacks are "necessary, but not sufficient" to reverse deteriorating confidence in Fed policy.
On equities, corporate earnings provided near-term support. Estee Lauder and Target posted strong quarterly results, while Moderna and Merck gained on positive initial data from a co-developed cancer vaccine. The S&P 500 rose 0.2 percent, marking its first gain in four days. The Dow Jones Industrial Average added 119 points, or 0.2 percent, and the Nasdaq composite gained 0.2 percent.
